Andrew St. John

“Andrew is driving the health economic value of pathology initiatives in Australia,” writes a nominator. The result of his work, a call for a value-based approach to laboratory medicine funding, has involved collaboration across global networks, particularly in the United Kingdom and Canada. Andrew is chair of the Australasian Association of Clinical Biochemists’ Health Economic Working Group, publishes regularly on issues affecting lab medicine professionals, and is frequently invited to present his work as an expert in health economics.

Part of the Power List 2015

Who are the most influential laboratory medicine professionals?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015